A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials, the company said Monday.
A COVID-19 vaccine candidate being produced by biotech company Moderna has shown to be 94.5% effective in Phase 3 clinical trials, the company said Monday.
The news about two covid-19 vaccines has been absolutely remarkable
The Government could face some “tough choices” if the vaccine produced byAstraZeneca and Oxford University is found to be less..